Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 35OTHER_GOV 3INDUSTRY 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 133Stomach Neoplasms 107Carcinoma, Hepatocellular 73Rectal Neoplasms 64Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Neoplasms 28Neoplasm Metastasis 20Gastrointestinal Neoplasms 19Esophageal Squamous Cell Carcinoma 19Cholangiocarcinoma 14Liver Neoplasms 13Breast Neoplasms 13Barrett Esophagus 9Lung Neoplasms 8Adenoma 8Motor Activity 7Liver Cirrhosis 7Digestive System Neoplasms 7Colonic Polyps 7Adenomatous Polyposis Coli 7Biliary Tract Neoplasms 6Anastomotic Leak 6Sarcopenia 5Inflammatory Bowel Diseases 5Hypertension, Portal 5Gallbladder Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 4

Interventions

apatinib 2Drug Evaluation 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Gastric Adenocarcinoma × Gastrointestinal × Clear all
NCT07610629 2026-05-28

RA-A-NP

Henan Cancer Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT04121039 2019-10-09

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Fujian Cancer Hospital

Phase 2 Unknown
116 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT02144727 2016-04-20

ADDICT

National Cancer Center, Korea

Phase 3 Unknown
1,880 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡